James Ede-Golightly
Board Member
Silence Therapeutics plc (SLN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Ede-Golightly
James Ede-Golightly is recorded as Board Member at Silence Therapeutics plc (SLN). Silence Therapeutics plc reported in an 8-K filed December 15, 2025 that James Ede-Golightly was appointed director of the Company, effective December 14, 2025.
“On the Effective Date, upon the recommendation of the Nominations Committee, the Board appointed James Ede-Golightly to serve as a director of the Company, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Silence Therapeutics plc
Other people whose current roles at this company are on record from its filings.
- Craig Tooman CEO
- Iain Ross CEO, Chairman
- Rhonda Hellums CFO, Board Member
- Dave Lemus Board Member
- Tim McInerney Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.